2 results
Approved WMOPending
Primary objective: to investigate whether HPA-axis responses during the ACTH (Synacthen) stimulation are differentially influenced by distinct hormonal contraceptives, as compared to responses measured during the natural menstrual cycle (luteal…
Approved WMOWill not start
The primary objectives of this study are to establish the efficacy and safety of APL-2 compared to eculizumab in patients with PNH who continue to have Hb levels <10.5 g/dL despite treatment with eculizumab.